Cubist pharmaceuticals stock

WebCubist Pharmaceuticals Inc stock price live 101.94, this page displays NASDAQ CBST stock exchange data. View the CBST premarket stock price ahead of the market session or assess the after hours quote. WebApr 6, 2024 · 14 brokers have issued 1 year price objectives for Apellis Pharmaceuticals' shares. Their APLS share price forecasts range from $40.00 to $139.00. On average, they predict the company's share price to reach $78.40 in the next twelve months. This suggests that the stock has a possible downside of 0.5%.

CUBIST PHARMACEUTICALS INC : Stock Price

WebApr 12, 2024 · Cubist Systematic Strategies LLC now owns 334,168 shares of the biopharmaceutical company’s stock valued at $4,662,000 after purchasing an additional 261,412 shares during the period. tsg tribeca cabinets https://nhukltd.com

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average …

WebApr 11, 2024 · In other Enanta Pharmaceuticals news, CEO Jay R. Luly sold 27,912 shares of the firm’s stock in a transaction on Monday, March 13th. The stock was sold at an average price of $45.16, for a total ... WebApr 12, 2024 · Cubist Systematic Strategies LLC now owns 138,891 shares of the scientific and technical instruments company’s stock valued at $5,178,000 after purchasing an additional 134,505 shares in the ... WebMar 15, 2013 · This was an investigator-initiated study funded by Cubist Pharmaceuticals. We acknowledge John Paul McRoberts (Anti-Infective Research Laboratory, Wayne State University) for assistance in the extended microbiological assessment and verification. ... R.K. is now employed by Cubist Pharmaceuticals and owns Cubist Pharmaceuticals … philoro goldkurs

Cubist Pharmaceuticals - CBST Stock Forecast, Price & News

Category:Cubist Pharmaceuticals Inc : Cubist Unveils Five-Year Strategic …

Tags:Cubist pharmaceuticals stock

Cubist pharmaceuticals stock

467037 (CBST) Stock Price, News, Quote & History - Yahoo Finance

WebApr 9, 2024 · ACADIA Pharmaceuticals Stock Up 0.4 %. ... Cubist Systematic Strategies LLC now owns 102,825 shares of the biopharmaceutical company’s stock worth $1,682,000 after buying an additional 74,952 ... WebAccess our live streaming chart for the Cubist Pharmaceuticals Inc stock, free of charge.

Cubist pharmaceuticals stock

Did you know?

WebCBST Stock Price Today ( ) Add to Watchlist. Quote; Insiders; Financials; Earnings; Filings; Analysts; Profile; Historical; Performance; CBST Stock Quote. Volume Open Day's Low … WebStock Price History Stock Splits Market Cap Stock split history for Merck since 1970. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. Compare MRK With Other Stocks From: To: Zoom:

WebThis Stock Option Agreement (the “Agreement”) governs an award (the “Award”) of stock options (“Stock Options”) to non-employee members of the Board of Directors of Cubist Pharmaceuticals, Inc. (the “Company”) who have been selected for participation (each such director, a “Participant”) under the Company’s 2014 Omnibus ... WebJul 14, 2024 · Cubist Pharmaceuticals Inc (NASDAQ:CBST) released its quarterly earnings data on Tuesday, October, 21st. The biopharmaceutical company reported $0.58 …

WebCubist Pharmaceuticals's latest funding round was a Acquired for on December 8, 2014. Cubist Pharmaceuticals's latest post-money valuation is from December 2014. Sign up for a free trial to see Cubist Pharmaceuticals's valuations in December 2014 and more. WebCubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. …

WebPhone Number 7812401261. Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), the first …

WebApr 12, 2024 · Cubist Systematic Strategies LLC now owns 334,168 shares of the biopharmaceutical company’s stock valued at $4,662,000 after buying an additional 261,412 shares during the period. Hedge funds... tsgt release 2022WebApr 10, 2024 · 10 analysts have issued 1 year price objectives for Ionis Pharmaceuticals' stock. Their IONS share price forecasts range from $27.00 to $67.00. On average, they predict the company's share price to reach $45.17 in the next year. This suggests a possible upside of 21.2% from the stock's current price. View analysts price targets for IONS or … tsg translation irvineWebFeb 11, 2014 · A high-level overview of Cubist Pharmaceuticals, Inc. (CBSTZ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … philoro freiburgWebDec 8, 2014 · Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that the companies have entered into a definitive agreement under which Merck will acquire … philoro goldpreisWebMar 28, 2024 · CUBIST PHARMACEUTICALS INC : Press releases relating to CUBIST PHARMACEUTICALS INC Investor relations Nasdaq: Nasdaq. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ 1 MarketScreener is worth more than 1000 Influencers! 100% Free Registration tsg troeger surface groupWebCubist Pharmaceuticals Inc. (CBST) Stock Price Today, News, Quotes, FAQs and Fundamentals 3rd Party Ad. Not an offer or recommendation by Stocktwits. See … philo rogersWebMar 23, 2024 · CUBIST PHARMACEUTICALS INC (NASDAQ:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CUBIST PHARMACEUTICALS INC Nasdaq: Nasdaq cubist pharmaceuticals inc Add to my list End-of-day quote Nasdaq - 09:24 2024 … CUBIST PHARMACEUTICALS INC : News, information and stories for CUBIST … CUBIST PHARMACEUTICALS INC : Company profile, business summary, … philoro freiburg preisliste